Top Markets
Coin of the day
Jiangsu Hengrui Medicine Co., Ltd. Jiangsu Hengrui Medicine Co., Ltd.

Jiangsu Hengrui Medicine Co., Ltd.

600276
Rank in Stocks #509
Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged... Jiangsu Hengrui Medicine Co., Ltd. is a global biopharmaceutical firm engaged in the full spectrum of pharmaceutical operations, from the initial discovery and development of medications to their manufacturing and worldwide distribution. The company is actively advancing a substantial pipeline of drug candidates, which includes Apatinib, Pyrotinib, Mecapegfilgrastim, SHR3680, SHR3162, SHR9549, SHR2554, SHR1459, SHR-1309, SHR-A1201, Camrelizumab, Famitinib, SHR-1316, SHR-1501, SHR-1603, SHR-1701, SHR-1702, and SHR-A1403. These prospective treatments are aimed at a diverse range of medical conditions, primarily focusing on oncology, metabolic disorders, pain management, and autoimmune diseases, among others. The enterprise was founded in 1970 and maintains its corporate headquarters in Lianyungang, China.
Share Price
$7.88
Market Cap
$50.25B
Change (1 day)
-1.11%
Change (1 year)
-7.06%
Country
CN
Trade Jiangsu Hengrui Medicine Co., Ltd. (600276)

Category

Stock split history for Jiangsu Hengrui Medicine Co., Ltd. (600276)
Jiangsu Hengrui Medicine Co., Ltd. stock (symbol: 600276) underwent a total of 0 stock splits.
The most recent stock split occurred on Aug 12, 2026.
One 600276 share bought prior to Aug 12, 2026 would equal to 0 600276 shares today.
Stock split list
Year Split Multiple Cumulative Multiple
Not enough data for the provided dates.
Stock splits for similar companies or competitors